Annotation Detail for MYBL1
Basic Information Top
| Gene Symbol: | MYBL1 ( A-MYB,AMYB,MGC120059,MGC120061 ) |
|---|---|
| Gene Full Name: | v-myb myeloblastosis viral oncogene homolog (avian)-like 1 |
| Band: | 8q13.1 |
| Quick Links | Entrez ID:4603; OMIM: 159405; Uniprot ID:MYBA_HUMAN; ENSEMBL ID: ENSG00000185697; HGNC ID: 7547 |
| Relate to Another Database: | SFARIGene; denovo-db |
Related Pathway Information| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C016601 | 4-hydroxytamoxifen | 4-hydroxytamoxifen results in increased expression of MYBL1 mRNA | increases expression | 19901195 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of MYBL1 protein | affects expression | 20106945 |
| D003913 | Dextroamphetamine | Dextroamphetamine results in decreased expression of MYBL1 mRNA | decreases expression | 12205029 |
| D003913 | Dextroamphetamine | SOD1 inhibits the reaction [Dextroamphetamine results in decreased expression of MYBL1 mRNA] | decreases expression|decreases reaction | 12205029 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of MYBL1 mRNA | decreases expression | 15725085 |
| C447119 | bazedoxifene acetate | bazedoxifene acetate results in decreased expression of MYBL1 mRNA | decreases expression | 19914376 |
| C006780 | bisphenol A | bisphenol A results in increased expression of MYBL1 mRNA | increases expression | 20739668 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of MYBL1 mRNA | decreases expression | 20106945 |
| D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MYBL1 mRNA | affects cotreatment|decreases expression | 19619570 |
| D004958 | Estradiol | Estradiol results in increased expression of MYBL1 mRNA | increases expression | 16202921 15913882 19619570 |
| C533894 | LG 100815 | LG 100815 results in decreased expression of MYBL1 mRNA | decreases expression | 16951191 |
| D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in increased expression of MYBL1 mRNA | increases expression | 12634122 |
| C062198 | octa-2,4,6-trienoic acid | octa-2,4,6-trienoic acid results in decreased expression of MYBL1 mRNA | decreases expression | 16951191 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of MYBL1 mRNA | increases expression | 18158353 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MYBL1 mRNA | affects binding|increases activity|increases expression | 19710929 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of MYBL1 mRNA | increases expression | 17879257 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of MYBL1 mRNA | decreases expression | 16014739 |
| D018038 | Sodium Selenite | Sodium Selenite results in decreased expression of MYBL1 mRNA | decreases expression | 18175754 |
| D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MYBL1 mRNA | affects cotreatment|decreases expression | 19619570 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of MYBL1 mRNA | decreases expression | 17517823 19901195 19619570 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of MYBL1 mRNA | decreases expression | 16604517 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of MYBL1 mRNA | increases expression | 19101580 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 8.19 | 11752688 14514962 15322242 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 8.19 | 8875741 | |
| MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 3.89 | 19490988 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 3.08 | 18653653 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 4.36 | 11798837 19825857 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 4.36 | 11473722 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 9.78 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 9.78 | 16835633 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 4.67 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 4.87 | 17306315 16712894 | |
| MESH:D000505 | Alopecia | Tretinoin | 3.58 | 15955085 | |
| MESH:D000550 | Amblyopia | Valproic Acid | 5.20 | 17688650 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.91 | 11748828 | |
| MESH:D001008 | Anxiety Disorders | Valproic Acid | 3.54 | 17497229 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 4.07 | 17460149 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 3.05 | 16412693 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 2.25 | 16292516 | |
| MESH:D001249 | Asthma | Tretinoin | 2.33 | 16456186 | |
| MESH:D001321 | Autistic Disorder | Valproic Acid | 2.01 | 17688650 18940202 18775368 18558336 16609825 18985861 19460635 20603192 17157402 17507914 18396377 15238991 18316065 19232924 18177632 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 4.36 | 16935849 | |
| MESH:D001714 | Bipolar Disorder | Valproic Acid | 3.05 | 20046352 17594078 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 21.62 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 21.62 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 21.62 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 21.62 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.76 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 7.93 | 15746008 | |
| MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 7.93 | 8888407 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 3.82 | 11985600 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 4.51 | 15306635 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 1.93 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 1.93 | 16675129 12948864 19861407 17289903 18497071 17018787 14630087 17261762 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 1.93 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 1.93 | 16166294 16443354 16873071 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 4.55 | 16813970 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 4.29 | 11589617 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 4.43 | 16111702 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.76 | 16835633 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 5.13 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Aflatoxin B1 | 8.81 | 21507988 12907637 12619106 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 8.81 | 11135700 14691202 15073043 16217749 15553829 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 8.81 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 8.81 | 15276417 16507464 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 8.81 | 1917145 | |
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 4.95 | 17123778 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 4.85 | 19014326 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 4.08 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 4.65 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 4.65 | 16051514 16096774 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 6.80 | 16170337 17124262 17287366 15728586 11754973 11179087 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 6.80 | 16120746 18670907 18850075 | |
| MESH:D002386 | Cataract | Tretinoin | 3.07 | 17460283 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 15.83 | 12371664 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 15.83 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitronitrosoguanidine | 15.83 | 2727394 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 15.83 | 19524636 20056578 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 4.55 | 16129372 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 2.69 | 20734317 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 3.12 | 16835633 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 7.65 | 19486331 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 7.65 | 19176532 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 5.13 | 16461808 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 4.71 | 15894690 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 5.70 | 15668235 15340226 12621046 16354765 8697196 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 5.70 | 9407595 | |
| MESH:D003092 | Colitis | Tretinoin | 3.66 | 17035595 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 1.86 | 20501625 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 3.02 | 17141729 14669216 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 4.14 | 12609071 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 5.36 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 5.36 | 10048152 15322242 20055451 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 5.36 | 9142499 16925845 9125849 17551590 8800419 10589399 14991402 9224671 9211117 9664655 | |
| MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 5.36 | 17688650 16575769 8888407 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 4.05 | 15213294 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 2.40 | 18249437 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 3.74 | 16285004 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 1.66 | 17107852 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 3.37 | 19279558 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 6.16 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 6.16 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 6.16 | 1733752 19641884 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 2.73 | 11462148 | |
| MESH:D004421 | Dystonia | Valproic Acid | 4.01 | 1851702 | |
| MESH:D004487 | Edema | pirinixic acid | 6.40 | 12083418 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 6.40 | 11000095 12711302 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 11.85 | 18230668 15322242 16714409 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 11.85 | 18230668 | |
| MESH:D016889 | Endometrial Neoplasms | 4-hydroxytamoxifen | 12.40 | 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 12.40 | 19148513 11473722 18566989 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 12.40 | 16569247 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.98 | 9294722 10568697 | |
| MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 4.11 | 3659116 17275665 | |
| MESH:D004828 | Epilepsies, Partial | Valproic Acid | 3.89 | 16628512 3922381 | |
| MESH:D004827 | Epilepsy | Valproic Acid | 2.91 | 18234410 20417680 | |
| MESH:D004832 | Epilepsy, Absence | Valproic Acid | 3.55 | 7562514 6426943 6254150 | |
| MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 4.26 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 4.03 | 3659116 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 2.30 | 12903497 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 8.72 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 8.72 | 16938888 9664655 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 18.43 | 15073043 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 18.43 | 19224547 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 18.43 | 19236843 20131406 | |
| MESH:D005234 | Fatty Liver | Valproic Acid | 18.43 | 14986274 19224547 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 3.42 | 11858732 | |
| MESH:D005315 | Fetal Diseases | Valproic Acid | 4.86 | 16575769 | |
| MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 4.09 | 8888407 18558336 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 14.50 | 12168785 12639820 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 14.50 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 14.50 | 17994277 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 4.22 | 16904648 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 4.64 | 16452187 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 4.18 | 8708960 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 2.98 | 17312396 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.57 | 10696789 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 3.15 | 16096774 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 5.13 | 16084493 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 6.46 | 10048152 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 6.46 | 14991402 9664655 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 2.51 | 20558911 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 4.39 | 15720958 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 3.29 | 11000095 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 8.13 | 19176532 18467677 16221962 19772884 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 8.13 | 15340226 16120746 12621046 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 5.00 | 15709030 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 3.11 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 3.72 | 17088409 | |
| MESH:D006849 | Hydrocephalus | Valproic Acid | 4.83 | 17688650 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 4.02 | 8697196 16354765 15340226 16959395 18606429 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 3.18 | 16870215 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 4.53 | 16778211 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 3.14 | 20558911 | |
| MESH:D006973 | Hypertension | Cyclosporine | 8.51 | 10903974 | |
| MESH:D006973 | Hypertension | Phenylephrine | 8.51 | 8949925 12717712 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 8.51 | 18670907 18850075 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 4.51 | 12791704 18502941 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 2.96 | 12646999 15346721 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 1.83 | 12200463 12878042 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 17.41 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 17.41 | 16393666 16627594 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 17.41 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 17.41 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 3.73 | 17994277 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 9.80 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 9.80 | 15992940 17551590 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 4.41 | 15604871 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 9.91 | 8314463 10903974 18776723 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 9.91 | 15618244 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 9.91 | 20008137 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 7.15 | 12371664 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 7.15 | 15610895 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 6.27 | 15070760 | |
| MESH:D007938 | Leukemia | Tretinoin | 6.27 | 17143497 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 3.75 | 12560223 17077332 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 4.27 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 3.39 | 14633726 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 9.34 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 9.34 | 16932348 19285840 16482212 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 6.07 | 19850784 17050201 16467208 16968895 20471514 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 6.07 | 17596541 16294345 19850784 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 6.07 | 17596541 16294345 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 7.54 | 19075265 16330433 17712046 17869043 17649720 12679006 15213294 12018890 16823087 15336539 16891316 11161223 15622746 11468182 19035177 16112521 12712474 17107899 9834237 17217047 19642359 16966277 15748426 16331271 19225113 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 7.54 | 19075265 17368321 19035177 15748426 16891316 9834237 16788101 16766008 17294898 17506722 16823087 19225113 17107899 19029980 17361223 12679006 19642359 17712046 16935935 17217047 17649720 16331271 17301526 16140955 17339181 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 4.31 | 16882451 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 3.27 | 9224671 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 4.88 | 14659978 14716833 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 4.88 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 4.88 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 4.88 | 18397230 16248980 | |
| MESH:D008113 | Liver Neoplasms | Aflatoxin B1 | 14.06 | 18177683 15890375 9163691 2125692 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 14.06 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 14.06 | 20007298 16377806 15890375 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 14.06 | 15276417 16712894 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 14.06 | 16984957 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Aflatoxin B1 | 9.66 | 8603461 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 9.66 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 9.66 | 12151625 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 3.31 | 15213294 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 3.14 | 19095001 | |
| MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 4.23 | 17228818 | |
| MESH:D008175 | Lung Neoplasms | Aflatoxin B1 | 4.80 | 14755239 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 4.80 | 19825857 11798837 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 4.80 | 19931552 17306315 15276417 17077188 16712894 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 4.80 | 11884234 19555203 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 4.02 | 14737004 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 2.53 | 17203775 11807958 11408345 16891317 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 4.45 | 19453300 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 2.77 | 17453147 | |
| MESH:D008545 | Melanoma | sodium arsenite | 3.32 | 16487513 19082730 | |
| MESH:D008545 | Melanoma | Tretinoin | 3.32 | 16752155 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 4.39 | 16940565 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 4.76 | 16801185 | |
| MESH:D053842 | Microsatellite Instability | Methylnitronitrosoguanidine | 5.85 | 17671175 | |
| MESH:D008881 | Migraine Disorders | Valproic Acid | 3.16 | 18803445 18765137 | |
| MESH:D009041 | Motion Sickness | Dextroamphetamine | 5.49 | 1613127 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 3.07 | 15949261 11468182 19417148 19549372 14977855 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 3.47 | 16239165 | |
| MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 3.99 | 8888407 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 4.64 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 12.17 | 16882451 16105982 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 12.17 | 17596541 | |
| MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 12.17 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 2.12 | 19151258 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.98 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 8.13 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 8.13 | 16411023 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 3.92 | 16624393 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 8.11 | 17405874 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 8.11 | 11559025 | |
| MESH:D009369 | Neoplasms | Tretinoin | 8.11 | 16594593 16946489 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 3.63 | 20056578 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 3.70 | 17289903 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 4.41 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 3.24 | 18481113 19348381 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 23.11 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 23.11 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 23.11 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 23.11 | 9125849 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 17.10 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 17.10 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 17.10 | 9142499 | |
| MESH:D009436 | Neural Tube Defects | Valproic Acid | 17.10 | 16359493 8888407 | |
| MESH:D009765 | Obesity | pirinixic acid | 1.80 | 20558911 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 4.95 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 11.18 | 19769630 16624393 12452020 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 11.18 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 11.18 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 11.18 | 16936753 | |
| MESH:D010146 | Pain | Tretinoin | 2.87 | 16870215 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 5.24 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 5.24 | 15976015 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 4.12 | 19927285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 4.22 | 12520081 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.52 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 3.18 | 12371664 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 16.05 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 16.05 | 11222880 11118676 11896295 11399792 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 16.05 | 20603192 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 10.42 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 10.42 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 1.87 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 1.87 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 1.87 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 1.87 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 1.87 | 18760546 | |
| MESH:D011507 | Proteinuria | Tretinoin | 3.56 | 16636307 | |
| MESH:D019310 | Pseudolymphoma | Valproic Acid | 4.51 | 12752131 11422049 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 2.21 | 16882103 | |
| MESH:D011625 | Pterygium | Tretinoin | 4.76 | 16723453 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 4.75 | 10548101 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 2.36 | 19058328 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.80 | 18990726 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 10.73 | 16116481 16283617 | |
| MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 10.73 | 19155313 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 3.92 | 16646077 | |
| MESH:D012559 | Schizophrenia | Valproic Acid | 2.06 | 19110320 15737665 | |
| MESH:D012640 | Seizures | Valproic Acid | 2.71 | 14763951 1511512 11044598 16876388 3137016 11738929 15475178 17978042 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 4.67 | 7327846 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 9.31 | 19524636 18572023 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 9.31 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 9.31 | 16467112 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 9.43 | 12854658 | |
| MESH:D016135 | Spinal Dysraphism | Valproic Acid | 9.43 | 19490988 | |
| MESH:D013226 | Status Epilepticus | Valproic Acid | 4.51 | 12833885 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 2.45 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 2.45 | 17261132 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 3.95 | 16045194 16684133 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.87 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 7.09 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 7.09 | 17045167 16026305 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 4.66 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 3.75 | 16051514 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 3.93 | 15213294 | |
| MESH:D014178 | Translocation, Genetic | Valproic Acid | 5.20 | 17262798 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 3.20 | 16040207 | |
| MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 4.49 | 3119515 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 5.11 | 11780464 20435036 12973940 12845720 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 5.11 | 16452187 17306315 11723127 16712894 | |
| MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 4.60 | 8888407 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 9.28 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 9.28 | 16129372 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 4.98 | 14652134 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 4.58 | 16752155 | |
| MESH:D014605 | Uveitis | Cyclosporine | 3.96 | 1336536 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 4.39 | 17056641 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.57 | 12125929 | |
| MESH:D014820 | Vitiligo | Tretinoin | 4.02 | 16761959 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 4.22 | 15886252 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 3.93 | 16287080 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 4.41 | 17120751 |
| No data |